1. IL-17A mediates inflammation-related retinal pigment epithelial cells injury via ERK signaling pathway.
- Author
-
Zhong HM, Shen BQ, Chen YH, Zhao XH, Huang XX, Zhou MW, and Sun XD
- Abstract
Aim: To investigate whether interleukin-17A (IL-17A) gets involved in the mechanisms of inflammation-related retinal pigment epithelium (RPE) cells injury and its significance in age-related macular degeneration (AMD)., Mrthods: A sodium iodate (NaIO
3 ) mouse model as well as IL-17A-/- mice were established. The effects of inflammatory cytokines in RPE cells and retinal microglia before and after NaIO3 modeling in vivo and in vitro , were investigated using immunofluorescence, immunoprotein blotting, and quantitative real-time fluorescence polymerase chain reaction (qRT-PCR), respectively. Interventions using recombinant IL-17A protein (rIL-17A) or IL-17A neutralizing antibody (IL-17A NAb) were used to observe the subsequent differences in fundus, fundus photography and optical coherence tomography (OCT), cell viability, and expression of oxidative stress-related markers before and after modeling, and to screen for key signaling pathways., Results: In the scenario of NaIO3 stimulation, RPE cells obviously tended to degenerate. Simultaneously proliferation and activation of retinal microglia was confirmed in NaIO3 -stimulated mice, whereas such effects induced by NaIO3 were significantly ameliorated with IL-17A NAb intervention or in IL-17A-/- mice. In addition, IL-17A promoted the proliferation and activation of microglia as well as oxidative damage and the secretion of inflammatory cytokines alongside NaIO3 -induced damage in RPE cells in vivo and ex vivo . Meanwhile, the extracellular signal-regulated kinase (ERK) signaling pathway was shown to be participated in the regulation of NaIO3 -induced RPE cells injury mediated by IL-17A in vivo and ex vivo , as IL-17A-induced inflammatory cytokines release in the NaIO3 model was alleviated after blocking the ERK pathway., Conclusion: IL-17A probably promotes the NaIO3 -induced RPE cells injury through exacerbating inflammation in terms of retinal microglia activation and inflammatory cytokines release via ERK signaling pathway. Inhibition of IL-17A may be a new potential target for dry AMD treatment., Competing Interests: Conflicts of Interest: Zhong HM, None; Shen BQ, None; Chen YH, None; Zhao XH, None; Huang XX, None; Zhou MW, None; Sun XD, None., (International Journal of Ophthalmology Press.)- Published
- 2025
- Full Text
- View/download PDF